ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

NIAID Advisors Ok Women & Infants Study Continuation

February 21, 1992

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978

CDC: About 8 Million Women Skipped Cervical Cancer Screening in the Past 5 Years

November 14, 2014

Diet & Nutrition, Carcinogenesis, Virus, Tobacco Committees Proposed For Elimination

May 6, 1977

New Version Of NCI Proposed IP Agreement Quiets Some Unease At Cooperative Groups; Advisors Urge “No Paralysis” While Awaiting New Language

November 13, 2009